Johnson & Johnson agrees to acquire Auris Health
Johnson & Johnson agreed to acquire Auris Health for approximately $3.4 billion in cash, with up to $2.35 billion in additional milestone payments.
Evidence notes
- The transaction brought the Monarch robotic endoscopy platform into Johnson & Johnson.
- The upfront consideration was approximately $3.4 billion in cash.
- Potential milestone payments could add up to $2.35 billion.
Company context
Auris Health develops the MONARCH robot-assisted endoscopy platform for bronchoscopic and urologic procedures. Johnson & Johnson acquired Auris in 2019, and the company remains part of Johnson & Johnson MedTech.